Skip to content
Rosebud Biosciences logo

Rosebud Biosciences

Rosebud Biosciences is a YC Winter 2022 (W22) company. Based in San Francisco, CA, USA; San Carlos, CA, USA. Team of 3.

  • AI-powered Drug Discovery
  • Pediatrics
  • Biotech

About Rosebud Biosciences

GPAgent's own fund-neutral profile, written from public information. Updated Oct 5, 2026.

Summary

Rosebud Biosciences grows patient-matched organoids, miniature lab-grown organs carrying the same genetic mutations as individual patients, to identify and screen drug candidates for rare genetic diseases. The company partners with therapeutics firms to run drug screening against these models and conducts its own drug discovery for diseases that have no approved treatments, with a focus on pediatric conditions. Its fetal-like organoids replace conventional disease models that cannot replicate early human development, enabling drug target discovery that standard approaches miss.

Go-to-market

Therapeutics companies engage Rosebud Biosciences as a research partner to screen their drug candidates; the company also runs independent discovery programs targeting rare pediatric diseases with no existing therapies.

From the Y Combinator listing

How Rosebud Biosciences describes itself in Y Combinator's public directory. Original listing (opens in a new tab)

Growing micro-organs to find new drugs

Rosebud Biosciences accelerates drug development by screening drugs against organoids (micro-organs) that have the same gene mutations as the patients. We partner with therapeutics companies to screen their drugs, and we perform our own drug discovery for rare diseases that have no existing treatments. Our organoids are also fetal-like and enable discovery of novel drug targets for pediatric diseases. This technology was validated at Stanford, published in a prestigious journal, and has already led to the discovery of a drug target in a pediatric heart disease that could not have been found using traditional disease models.

Facts

Industry
Healthcare / Healthcare -> Drug Discovery and Delivery
Location
San Francisco, CA, USA; San Carlos, CA, USA
Team size
3
Status
Active
Stage
Early

Founders (2)

Score every batch against your own thesis

GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.

How Accelerator intelligence works